Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC
Article in The Oncologist (February 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
ALK Deletion Exons 2 to 19: Case Report of a Rare ALK Inhibitor–Responsive Lung Cancer Driver Oncogene
Article in JTO Clinical and Research Reports (February 2023)
Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors
Article in PLOS ONE (March 2022)